Trial compares different doses of Merck's Zocor

11/9/2008 | Reuters

Scientists at the University of Oxford in the U.K. found that 80-mg doses of simvastatin, sold by Merck & Co. as Zocor, lowered "bad" LDL cholesterol by about 14% more than 20-mg doses during an average 6.7 years of treatment. Although researchers concluded that high-dose Zocor was safe, it was linked to 53 cases of myopathy, a muscle-weakening illness, compared with three patients who took lower doses.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations